

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axonemal dynein complex assembly (GO:0070286) | 7.37159037 |
| 2 | cilium or flagellum-dependent cell motility (GO:0001539) | 5.76401283 |
| 3 | cilium movement (GO:0003341) | 5.37249313 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.22660407 |
| 5 | motile cilium assembly (GO:0044458) | 5.12536103 |
| 6 | synaptic vesicle maturation (GO:0016188) | 4.94976616 |
| 7 | synaptic vesicle exocytosis (GO:0016079) | 4.92699742 |
| 8 | neuronal action potential propagation (GO:0019227) | 4.79658725 |
| 9 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.78113252 |
| 10 | neuron cell-cell adhesion (GO:0007158) | 4.64130312 |
| 11 | glutamate secretion (GO:0014047) | 4.61461621 |
| 12 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.59533374 |
| 13 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.58175130 |
| 14 | vocalization behavior (GO:0071625) | 4.56925235 |
| 15 | epithelial cilium movement (GO:0003351) | 4.56313205 |
| 16 | locomotory exploration behavior (GO:0035641) | 4.56305347 |
| 17 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 4.49085480 |
| 18 | protein localization to synapse (GO:0035418) | 4.38928278 |
| 19 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.38527700 |
| 20 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.10214115 |
| 21 | regulation of synaptic vesicle transport (GO:1902803) | 4.08284417 |
| 22 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.92254507 |
| 23 | axoneme assembly (GO:0035082) | 3.89409169 |
| 24 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.85773691 |
| 25 | left/right pattern formation (GO:0060972) | 3.85322430 |
| 26 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.83842658 |
| 27 | exploration behavior (GO:0035640) | 3.81419379 |
| 28 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.80552311 |
| 29 | neurotransmitter secretion (GO:0007269) | 3.78034939 |
| 30 | synaptic transmission, glutamatergic (GO:0035249) | 3.72925153 |
| 31 | glutamate receptor signaling pathway (GO:0007215) | 3.71476131 |
| 32 | neuron-neuron synaptic transmission (GO:0007270) | 3.69555005 |
| 33 | neuromuscular process controlling posture (GO:0050884) | 3.69389236 |
| 34 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.59364422 |
| 35 | regulation of ARF protein signal transduction (GO:0032012) | 3.57562595 |
| 36 | cerebellar granule cell differentiation (GO:0021707) | 3.57180449 |
| 37 | presynaptic membrane assembly (GO:0097105) | 3.52299132 |
| 38 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.51101063 |
| 39 | long-term memory (GO:0007616) | 3.49140640 |
| 40 | detection of calcium ion (GO:0005513) | 3.49123722 |
| 41 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.47325554 |
| 42 | transmission of nerve impulse (GO:0019226) | 3.44760527 |
| 43 | positive regulation of membrane potential (GO:0045838) | 3.44665750 |
| 44 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.42785159 |
| 45 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.38358014 |
| 46 | presynaptic membrane organization (GO:0097090) | 3.37697338 |
| 47 | neuron recognition (GO:0008038) | 3.34270209 |
| 48 | long-term synaptic potentiation (GO:0060291) | 3.34265950 |
| 49 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.33855826 |
| 50 | cellular potassium ion homeostasis (GO:0030007) | 3.32451219 |
| 51 | neurotransmitter transport (GO:0006836) | 3.31066676 |
| 52 | regulation of synapse structural plasticity (GO:0051823) | 3.29428340 |
| 53 | gamma-aminobutyric acid transport (GO:0015812) | 3.28923249 |
| 54 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.25172721 |
| 55 | regulation of neurotransmitter secretion (GO:0046928) | 3.24988349 |
| 56 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.24666509 |
| 57 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.24316862 |
| 58 | regulation of postsynaptic membrane potential (GO:0060078) | 3.20369302 |
| 59 | sodium ion export (GO:0071436) | 3.18902308 |
| 60 | regulation of synaptic plasticity (GO:0048167) | 3.17968279 |
| 61 | dendritic spine morphogenesis (GO:0060997) | 3.15747103 |
| 62 | synaptic vesicle endocytosis (GO:0048488) | 3.13652274 |
| 63 | layer formation in cerebral cortex (GO:0021819) | 3.12525359 |
| 64 | postsynaptic membrane organization (GO:0001941) | 3.11494906 |
| 65 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.11160864 |
| 66 | regulation of vesicle fusion (GO:0031338) | 3.10584528 |
| 67 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.09753821 |
| 68 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.06668379 |
| 69 | neuronal ion channel clustering (GO:0045161) | 3.05392624 |
| 70 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.05363049 |
| 71 | positive regulation of synapse maturation (GO:0090129) | 3.02764161 |
| 72 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.02609719 |
| 73 | regulation of neurotransmitter transport (GO:0051588) | 3.01788579 |
| 74 | membrane depolarization during action potential (GO:0086010) | 3.00826633 |
| 75 | response to auditory stimulus (GO:0010996) | 3.00825790 |
| 76 | adult walking behavior (GO:0007628) | 2.99576731 |
| 77 | regulation of neurotransmitter levels (GO:0001505) | 2.97749691 |
| 78 | axon ensheathment in central nervous system (GO:0032291) | 2.97620798 |
| 79 | central nervous system myelination (GO:0022010) | 2.97620798 |
| 80 | membrane hyperpolarization (GO:0060081) | 2.97503103 |
| 81 | axonal fasciculation (GO:0007413) | 2.96306242 |
| 82 | mating behavior (GO:0007617) | 2.93147839 |
| 83 | membrane depolarization (GO:0051899) | 2.92587224 |
| 84 | synaptic transmission (GO:0007268) | 2.89231311 |
| 85 | dendritic spine organization (GO:0097061) | 2.88279799 |
| 86 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.86953740 |
| 87 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.84707682 |
| 88 | activation of protein kinase A activity (GO:0034199) | 2.84371073 |
| 89 | regulation of cilium movement (GO:0003352) | 2.84341611 |
| 90 | regulation of glutamate secretion (GO:0014048) | 2.84195835 |
| 91 | microtubule bundle formation (GO:0001578) | 2.83744503 |
| 92 | positive regulation of neurotransmitter transport (GO:0051590) | 2.82321683 |
| 93 | behavioral response to cocaine (GO:0048148) | 2.82189198 |
| 94 | L-amino acid import (GO:0043092) | 2.81395144 |
| 95 | synapse assembly (GO:0007416) | 2.79354658 |
| 96 | learning (GO:0007612) | 2.79275590 |
| 97 | neuronal action potential (GO:0019228) | 2.79233090 |
| 98 | negative regulation of neurotransmitter transport (GO:0051589) | 2.78933983 |
| 99 | protein localization to cilium (GO:0061512) | 2.78690166 |
| 100 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.78078239 |
| 101 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.77883751 |
| 102 | regulation of synaptic transmission (GO:0050804) | 2.77879978 |
| 103 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.77622173 |
| 104 | positive regulation of synaptic transmission (GO:0050806) | 2.77619355 |
| 105 | neuromuscular process controlling balance (GO:0050885) | 2.76899715 |
| 106 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.75583063 |
| 107 | proline transport (GO:0015824) | 2.75269050 |
| 108 | glycine transport (GO:0015816) | 2.74713188 |
| 109 | auditory behavior (GO:0031223) | 2.71923318 |
| 110 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.71839790 |
| 111 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.71817013 |
| 112 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.71770212 |
| 113 | striatum development (GO:0021756) | 2.70906890 |
| 114 | response to histamine (GO:0034776) | 2.70259298 |
| 115 | behavioral defense response (GO:0002209) | 2.69222039 |
| 116 | behavioral fear response (GO:0001662) | 2.69222039 |
| 117 | potassium ion homeostasis (GO:0055075) | 2.66312859 |
| 118 | regulation of microtubule-based movement (GO:0060632) | 2.66218071 |
| 119 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.61310070 |
| 120 | establishment of mitochondrion localization (GO:0051654) | 2.58037072 |
| 121 | long term synaptic depression (GO:0060292) | 2.57656315 |
| 122 | dopamine receptor signaling pathway (GO:0007212) | 2.56953409 |
| 123 | chemosensory behavior (GO:0007635) | 2.53449614 |
| 124 | regulation of autophagic vacuole assembly (GO:2000785) | 2.53161759 |
| 125 | ventricular system development (GO:0021591) | 2.51532127 |
| 126 | neurotransmitter catabolic process (GO:0042135) | 2.51453379 |
| 127 | regulation of synapse maturation (GO:0090128) | 2.51094151 |
| 128 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.48677032 |
| 129 | regulation of female receptivity (GO:0045924) | 2.44719759 |
| 130 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.42162806 |
| 131 | macroautophagy (GO:0016236) | 2.36196132 |
| 132 | cell migration in hindbrain (GO:0021535) | 2.35491107 |
| 133 | signal release (GO:0023061) | 2.34280060 |
| 134 | lung epithelium development (GO:0060428) | 2.32308424 |
| 135 | potassium ion import (GO:0010107) | 2.31997006 |
| 136 | cellular sodium ion homeostasis (GO:0006883) | 2.26505916 |
| 137 | mitochondrion transport along microtubule (GO:0047497) | 2.26166399 |
| 138 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.26166399 |
| 139 | cell differentiation in hindbrain (GO:0021533) | 2.24606847 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.85297193 |
| 2 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 4.03778927 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.73706519 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.18921087 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.05159678 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.97310310 |
| 7 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.71710385 |
| 8 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.62854634 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.61471614 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.61471614 |
| 11 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.58062968 |
| 12 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.56077735 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.53544408 |
| 14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.51230531 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.50312365 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.49742466 |
| 17 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.42974261 |
| 18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.36569131 |
| 19 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.36429252 |
| 20 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.34446048 |
| 21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.34090162 |
| 22 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.31054188 |
| 23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.27062555 |
| 24 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.26433238 |
| 25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.12062226 |
| 26 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.10062147 |
| 27 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.01181190 |
| 28 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.92882100 |
| 29 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.90512874 |
| 30 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.80764780 |
| 31 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.79993337 |
| 32 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.78661272 |
| 33 | * P68_20966046_ChIP-Seq_HELA_Human | 1.78564145 |
| 34 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.77479521 |
| 35 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.76632959 |
| 36 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.74498407 |
| 37 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.74414925 |
| 38 | KDM2B_26808549_Chip-Seq_K562_Human | 1.74171514 |
| 39 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.72402553 |
| 40 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.69367356 |
| 41 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.65745227 |
| 42 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.65283245 |
| 43 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.64045319 |
| 44 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.60858945 |
| 45 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.54103504 |
| 46 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.48344913 |
| 47 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.47784121 |
| 48 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.44632363 |
| 49 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.44536851 |
| 50 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.43909715 |
| 51 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.43346341 |
| 52 | VDR_22108803_ChIP-Seq_LS180_Human | 1.42615132 |
| 53 | P300_19829295_ChIP-Seq_ESCs_Human | 1.42083710 |
| 54 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.41106904 |
| 55 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.38911631 |
| 56 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.37624178 |
| 57 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.36406731 |
| 58 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.36252516 |
| 59 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.35021390 |
| 60 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.34773829 |
| 61 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.34014776 |
| 62 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.32598760 |
| 63 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.32336720 |
| 64 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.32288318 |
| 65 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.30985848 |
| 66 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.30844043 |
| 67 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.30479084 |
| 68 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.29613762 |
| 69 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.29090355 |
| 70 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.28547699 |
| 71 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.28027286 |
| 72 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.26967320 |
| 73 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.25698156 |
| 74 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.24884014 |
| 75 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.23460701 |
| 76 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.23164696 |
| 77 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.22578513 |
| 78 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.22468380 |
| 79 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.22043278 |
| 80 | STAT3_23295773_ChIP-Seq_U87_Human | 1.20369324 |
| 81 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.19436070 |
| 82 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.18669470 |
| 83 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.18626967 |
| 84 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.18145832 |
| 85 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.17737510 |
| 86 | AR_25329375_ChIP-Seq_VCAP_Human | 1.16665332 |
| 87 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.15471912 |
| 88 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.14688229 |
| 89 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.13156716 |
| 90 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.12941363 |
| 91 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.12690636 |
| 92 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.12457600 |
| 93 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 1.10813972 |
| 94 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.10742147 |
| 95 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 1.09319159 |
| 96 | TCF4_23295773_ChIP-Seq_U87_Human | 1.08257550 |
| 97 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.08184932 |
| 98 | AR_19668381_ChIP-Seq_PC3_Human | 1.06139970 |
| 99 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.05555247 |
| 100 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.04531435 |
| 101 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.03921590 |
| 102 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.03648113 |
| 103 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.02781858 |
| 104 | SA1_27219007_Chip-Seq_Bcells_Human | 1.02156761 |
| 105 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.02143443 |
| 106 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.02033118 |
| 107 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.01728821 |
| 108 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.01168740 |
| 109 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.00752762 |
| 110 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.00677544 |
| 111 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.00516380 |
| 112 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.00397762 |
| 113 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.00295770 |
| 114 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.99751830 |
| 115 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.99562528 |
| 116 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.99492644 |
| 117 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.98965193 |
| 118 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.98869874 |
| 119 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.97434865 |
| 120 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.97299190 |
| 121 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97258589 |
| 122 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.96558575 |
| 123 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.95806381 |
| 124 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.95530016 |
| 125 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.94734663 |
| 126 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.94682981 |
| 127 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.94173781 |
| 128 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.93821268 |
| 129 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.93809089 |
| 130 | FUS_26573619_Chip-Seq_HEK293_Human | 0.93570865 |
| 131 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.93547321 |
| 132 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.93414498 |
| 133 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.91843867 |
| 134 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.91584182 |
| 135 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.89727320 |
| 136 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.89246097 |
| 137 | JUN_21703547_ChIP-Seq_K562_Human | 0.89192510 |
| 138 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.89024453 |
| 139 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.88822593 |
| 140 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.88596746 |
| 141 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.88002671 |
| 142 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.87957644 |
| 143 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.87677107 |
| 144 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.86680436 |
| 145 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86108638 |
| 146 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.86011153 |
| 147 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.85589953 |
| 148 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.84758137 |
| 149 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.83708337 |
| 150 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.83670648 |
| 151 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.83625636 |
| 152 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.82939795 |
| 153 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.82312789 |
| 154 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.82220403 |
| 155 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.82165424 |
| 156 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.82057959 |
| 157 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.81471027 |
| 158 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.81202714 |
| 159 | KDM2B_26808549_Chip-Seq_REH_Human | 0.79772202 |
| 160 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.79613506 |
| 161 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.79500429 |
| 162 | * CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.78911761 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.32528742 |
| 2 | MP0003880_abnormal_central_pattern | 4.81800980 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.74437665 |
| 4 | MP0004270_analgesia | 3.72066300 |
| 5 | MP0009745_abnormal_behavioral_response | 3.21777220 |
| 6 | MP0002064_seizures | 3.10816130 |
| 7 | MP0001968_abnormal_touch/_nociception | 3.02659728 |
| 8 | MP0002653_abnormal_ependyma_morphology | 3.01980798 |
| 9 | MP0002063_abnormal_learning/memory/cond | 2.95553799 |
| 10 | MP0009046_muscle_twitch | 2.93388223 |
| 11 | MP0002272_abnormal_nervous_system | 2.88463121 |
| 12 | MP0005423_abnormal_somatic_nervous | 2.80969423 |
| 13 | MP0002572_abnormal_emotion/affect_behav | 2.68367689 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.67284082 |
| 15 | MP0002822_catalepsy | 2.50360261 |
| 16 | MP0001486_abnormal_startle_reflex | 2.50118642 |
| 17 | MP0002736_abnormal_nociception_after | 2.46164818 |
| 18 | MP0002735_abnormal_chemical_nociception | 2.39529302 |
| 19 | MP0001501_abnormal_sleep_pattern | 2.11704764 |
| 20 | MP0001440_abnormal_grooming_behavior | 2.11493891 |
| 21 | MP0002733_abnormal_thermal_nociception | 2.07657812 |
| 22 | MP0006276_abnormal_autonomic_nervous | 2.06510812 |
| 23 | MP0001970_abnormal_pain_threshold | 2.05518935 |
| 24 | MP0001529_abnormal_vocalization | 2.03407689 |
| 25 | MP0002067_abnormal_sensory_capabilities | 2.01758698 |
| 26 | MP0005646_abnormal_pituitary_gland | 1.99116401 |
| 27 | MP0001905_abnormal_dopamine_level | 1.86331467 |
| 28 | MP0003329_amyloid_beta_deposits | 1.85643144 |
| 29 | MP0001984_abnormal_olfaction | 1.81994874 |
| 30 | MP0004858_abnormal_nervous_system | 1.81905124 |
| 31 | MP0008875_abnormal_xenobiotic_pharmacok | 1.80318644 |
| 32 | MP0003172_abnormal_lysosome_physiology | 1.79159967 |
| 33 | MP0002184_abnormal_innervation | 1.74214552 |
| 34 | MP0008569_lethality_at_weaning | 1.72366480 |
| 35 | MP0004142_abnormal_muscle_tone | 1.66357222 |
| 36 | MP0002557_abnormal_social/conspecific_i | 1.64759832 |
| 37 | MP0005551_abnormal_eye_electrophysiolog | 1.60727754 |
| 38 | MP0000778_abnormal_nervous_system | 1.60130912 |
| 39 | MP0004924_abnormal_behavior | 1.59286781 |
| 40 | MP0005386_behavior/neurological_phenoty | 1.59286781 |
| 41 | MP0009780_abnormal_chondrocyte_physiolo | 1.58111198 |
| 42 | MP0000955_abnormal_spinal_cord | 1.49745327 |
| 43 | MP0005645_abnormal_hypothalamus_physiol | 1.49171821 |
| 44 | MP0002882_abnormal_neuron_morphology | 1.48711793 |
| 45 | MP0004811_abnormal_neuron_physiology | 1.47201097 |
| 46 | MP0000920_abnormal_myelination | 1.46861916 |
| 47 | MP0003122_maternal_imprinting | 1.45322919 |
| 48 | MP0002909_abnormal_adrenal_gland | 1.45079679 |
| 49 | MP0002066_abnormal_motor_capabilities/c | 1.41624062 |
| 50 | MP0001502_abnormal_circadian_rhythm | 1.41502490 |
| 51 | MP0004133_heterotaxia | 1.39937382 |
| 52 | MP0010386_abnormal_urinary_bladder | 1.38583437 |
| 53 | MP0002229_neurodegeneration | 1.32108772 |
| 54 | MP0003879_abnormal_hair_cell | 1.31609423 |
| 55 | MP0000751_myopathy | 1.31379803 |
| 56 | MP0004885_abnormal_endolymph | 1.30763010 |
| 57 | MP0005058_abnormal_lysosome_morphology | 1.24318905 |
| 58 | MP0003633_abnormal_nervous_system | 1.21982901 |
| 59 | MP0001986_abnormal_taste_sensitivity | 1.19573548 |
| 60 | MP0000013_abnormal_adipose_tissue | 1.18975400 |
| 61 | MP0002837_dystrophic_cardiac_calcinosis | 1.18860221 |
| 62 | MP0004145_abnormal_muscle_electrophysio | 1.18608007 |
| 63 | MP0004742_abnormal_vestibular_system | 1.18599428 |
| 64 | MP0001188_hyperpigmentation | 1.17607412 |
| 65 | MP0001765_abnormal_ion_homeostasis | 1.13578707 |
| 66 | MP0003634_abnormal_glial_cell | 1.12414798 |
| 67 | MP0003631_nervous_system_phenotype | 1.12202711 |
| 68 | MP0005377_hearing/vestibular/ear_phenot | 1.10894537 |
| 69 | MP0003878_abnormal_ear_physiology | 1.10894537 |
| 70 | MP0006072_abnormal_retinal_apoptosis | 1.07932360 |
| 71 | MP0003787_abnormal_imprinting | 1.03401047 |
| 72 | MP0002638_abnormal_pupillary_reflex | 1.02138845 |
| 73 | MP0002152_abnormal_brain_morphology | 1.00863906 |
| 74 | MP0004043_abnormal_pH_regulation | 1.00700703 |
| 75 | MP0002752_abnormal_somatic_nervous | 0.99851474 |
| 76 | MP0001963_abnormal_hearing_physiology | 0.98561009 |
| 77 | MP0000681_abnormal_thyroid_gland | 0.97760009 |
| 78 | MP0003283_abnormal_digestive_organ | 0.97153432 |
| 79 | MP0001485_abnormal_pinna_reflex | 0.94606699 |
| 80 | MP0003690_abnormal_glial_cell | 0.93213439 |
| 81 | MP0005253_abnormal_eye_physiology | 0.92130614 |
| 82 | MP0004085_abnormal_heartbeat | 0.90440025 |
| 83 | MP0003123_paternal_imprinting | 0.88577969 |
| 84 | MP0000566_synostosis | 0.88544547 |
| 85 | MP0002069_abnormal_eating/drinking_beha | 0.88504044 |
| 86 | MP0003632_abnormal_nervous_system | 0.87960253 |
| 87 | MP0001944_abnormal_pancreas_morphology | 0.87160925 |
| 88 | MP0000631_abnormal_neuroendocrine_gland | 0.83700619 |
| 89 | MP0005535_abnormal_body_temperature | 0.82178593 |
| 90 | MP0005171_absent_coat_pigmentation | 0.81344385 |
| 91 | MP0004215_abnormal_myocardial_fiber | 0.80316633 |
| 92 | MP0002090_abnormal_vision | 0.77688407 |
| 93 | MP0008872_abnormal_physiological_respon | 0.77317787 |
| 94 | MP0003075_altered_response_to | 0.76750208 |
| 95 | MP0002693_abnormal_pancreas_physiology | 0.73888690 |
| 96 | MP0003137_abnormal_impulse_conducting | 0.72924110 |
| 97 | MP0008874_decreased_physiological_sensi | 0.72448126 |
| 98 | MP0002249_abnormal_larynx_morphology | 0.71577882 |
| 99 | MP0005409_darkened_coat_color | 0.71558550 |
| 100 | MP0002876_abnormal_thyroid_physiology | 0.70500452 |
| 101 | MP0005394_taste/olfaction_phenotype | 0.70204435 |
| 102 | MP0005499_abnormal_olfactory_system | 0.70204435 |
| 103 | MP0000604_amyloidosis | 0.69146571 |
| 104 | MP0005410_abnormal_fertilization | 0.68115542 |
| 105 | MP0004019_abnormal_vitamin_homeostasis | 0.67614087 |
| 106 | MP0001664_abnormal_digestion | 0.66915142 |
| 107 | MP0001177_atelectasis | 0.66622817 |
| 108 | MP0009278_abnormal_bone_marrow | 0.66594218 |
| 109 | MP0008789_abnormal_olfactory_epithelium | 0.66513974 |
| 110 | MP0001756_abnormal_urination | 0.66224992 |
| 111 | MP0000639_abnormal_adrenal_gland | 0.63709461 |
| 112 | MP0002928_abnormal_bile_duct | 0.63299836 |
| 113 | MP0000026_abnormal_inner_ear | 0.61572935 |
| 114 | MP0004036_abnormal_muscle_relaxation | 0.60846170 |
| 115 | MP0000747_muscle_weakness | 0.58072435 |
| 116 | MP0003183_abnormal_peptide_metabolism | 0.57491672 |
| 117 | MP0005379_endocrine/exocrine_gland_phen | 0.57386819 |
| 118 | MP0005195_abnormal_posterior_eye | 0.57245096 |
| 119 | MP0004233_abnormal_muscle_weight | 0.54981354 |
| 120 | MP0005623_abnormal_meninges_morphology | 0.53240371 |
| 121 | MP0004484_altered_response_of | 0.52817004 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 8.12902289 |
| 2 | Abnormal respiratory epithelium morphology (HP:0012253) | 6.77591332 |
| 3 | Abnormal respiratory motile cilium morphology (HP:0005938) | 6.77591332 |
| 4 | Abnormal respiratory motile cilium physiology (HP:0012261) | 6.71994258 |
| 5 | Focal motor seizures (HP:0011153) | 6.66167706 |
| 6 | Abnormal ciliary motility (HP:0012262) | 6.36536493 |
| 7 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 6.30539076 |
| 8 | Absent/shortened dynein arms (HP:0200106) | 6.30539076 |
| 9 | Rhinitis (HP:0012384) | 6.19402164 |
| 10 | Myokymia (HP:0002411) | 6.07053244 |
| 11 | Focal seizures (HP:0007359) | 5.04352995 |
| 12 | Atonic seizures (HP:0010819) | 4.84629521 |
| 13 | Chronic bronchitis (HP:0004469) | 4.82384529 |
| 14 | Nasal polyposis (HP:0100582) | 4.74319186 |
| 15 | Epileptic encephalopathy (HP:0200134) | 4.56470059 |
| 16 | Visual hallucinations (HP:0002367) | 4.52407180 |
| 17 | Bronchiectasis (HP:0002110) | 4.39129566 |
| 18 | Febrile seizures (HP:0002373) | 4.17780713 |
| 19 | Abnormality of the nasal mucosa (HP:0000433) | 3.97305793 |
| 20 | Progressive cerebellar ataxia (HP:0002073) | 3.89583784 |
| 21 | Absence seizures (HP:0002121) | 3.88047815 |
| 22 | Dialeptic seizures (HP:0011146) | 3.67613687 |
| 23 | Ankle clonus (HP:0011448) | 3.58029624 |
| 24 | Supranuclear gaze palsy (HP:0000605) | 3.55646564 |
| 25 | Generalized tonic-clonic seizures (HP:0002069) | 3.54807621 |
| 26 | Action tremor (HP:0002345) | 3.53444389 |
| 27 | Dysmetria (HP:0001310) | 3.12317645 |
| 28 | Neurofibrillary tangles (HP:0002185) | 3.11585975 |
| 29 | Atelectasis (HP:0100750) | 3.05319216 |
| 30 | Infertility (HP:0000789) | 3.02860807 |
| 31 | Truncal ataxia (HP:0002078) | 3.01916945 |
| 32 | Retinal dysplasia (HP:0007973) | 3.01195372 |
| 33 | Obstructive sleep apnea (HP:0002870) | 2.99884352 |
| 34 | Dysdiadochokinesis (HP:0002075) | 2.98620138 |
| 35 | Scanning speech (HP:0002168) | 2.97845621 |
| 36 | Abnormality of the corticospinal tract (HP:0002492) | 2.95453660 |
| 37 | Broad-based gait (HP:0002136) | 2.94030258 |
| 38 | Gaze-evoked nystagmus (HP:0000640) | 2.93992267 |
| 39 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.90981154 |
| 40 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.90981154 |
| 41 | Anxiety (HP:0000739) | 2.90862750 |
| 42 | Pheochromocytoma (HP:0002666) | 2.89827275 |
| 43 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.89655146 |
| 44 | Recurrent sinusitis (HP:0011108) | 2.89049647 |
| 45 | Spastic gait (HP:0002064) | 2.88107327 |
| 46 | Insidious onset (HP:0003587) | 2.79366449 |
| 47 | Termporal pattern (HP:0011008) | 2.79366449 |
| 48 | Depression (HP:0000716) | 2.77702815 |
| 49 | Hand muscle atrophy (HP:0009130) | 2.70638733 |
| 50 | Cerebral inclusion bodies (HP:0100314) | 2.70344315 |
| 51 | Occipital encephalocele (HP:0002085) | 2.68483354 |
| 52 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.68166680 |
| 53 | Hyperventilation (HP:0002883) | 2.64267810 |
| 54 | Postural instability (HP:0002172) | 2.63398936 |
| 55 | Bronchitis (HP:0012387) | 2.60632808 |
| 56 | Limb dystonia (HP:0002451) | 2.59368541 |
| 57 | Papilledema (HP:0001085) | 2.58364827 |
| 58 | Neuroendocrine neoplasm (HP:0100634) | 2.57863249 |
| 59 | Abnormal eating behavior (HP:0100738) | 2.55243868 |
| 60 | Poor eye contact (HP:0000817) | 2.52332055 |
| 61 | Epileptiform EEG discharges (HP:0011182) | 2.51844466 |
| 62 | Recurrent otitis media (HP:0000403) | 2.48772500 |
| 63 | Chronic sinusitis (HP:0011109) | 2.47161918 |
| 64 | Gait imbalance (HP:0002141) | 2.46789686 |
| 65 | Amblyopia (HP:0000646) | 2.45041777 |
| 66 | Hemiparesis (HP:0001269) | 2.43820225 |
| 67 | EEG with generalized epileptiform discharges (HP:0011198) | 2.42934833 |
| 68 | Urinary urgency (HP:0000012) | 2.36653580 |
| 69 | Male infertility (HP:0003251) | 2.34165009 |
| 70 | Upper limb amyotrophy (HP:0009129) | 2.30807170 |
| 71 | Distal upper limb amyotrophy (HP:0007149) | 2.30807170 |
| 72 | Lower limb muscle weakness (HP:0007340) | 2.28316686 |
| 73 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.27909012 |
| 74 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.27909012 |
| 75 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.27909012 |
| 76 | Progressive inability to walk (HP:0002505) | 2.27700853 |
| 77 | Mucopolysacchariduria (HP:0008155) | 2.27328791 |
| 78 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.27328791 |
| 79 | Hypsarrhythmia (HP:0002521) | 2.26287543 |
| 80 | Delusions (HP:0000746) | 2.24574958 |
| 81 | Abnormal social behavior (HP:0012433) | 2.24438240 |
| 82 | Impaired social interactions (HP:0000735) | 2.24438240 |
| 83 | Sleep apnea (HP:0010535) | 2.23410198 |
| 84 | Intention tremor (HP:0002080) | 2.22374687 |
| 85 | Congenital primary aphakia (HP:0007707) | 2.20462277 |
| 86 | Stridor (HP:0010307) | 2.19017397 |
| 87 | Torticollis (HP:0000473) | 2.18857586 |
| 88 | Hyperthyroidism (HP:0000836) | 2.18606716 |
| 89 | Mutism (HP:0002300) | 2.16600732 |
| 90 | Impaired smooth pursuit (HP:0007772) | 2.15341939 |
| 91 | Bradykinesia (HP:0002067) | 2.14975682 |
| 92 | Growth hormone excess (HP:0000845) | 2.14677501 |
| 93 | Abnormality of binocular vision (HP:0011514) | 2.11822293 |
| 94 | Diplopia (HP:0000651) | 2.11822293 |
| 95 | Medial flaring of the eyebrow (HP:0010747) | 2.11099600 |
| 96 | Excessive salivation (HP:0003781) | 2.10760252 |
| 97 | Drooling (HP:0002307) | 2.10760252 |
| 98 | Chronic otitis media (HP:0000389) | 2.09760189 |
| 99 | Ventricular fibrillation (HP:0001663) | 2.06766688 |
| 100 | Nephronophthisis (HP:0000090) | 2.06388778 |
| 101 | Fetal akinesia sequence (HP:0001989) | 2.06191749 |
| 102 | Absent speech (HP:0001344) | 2.05049818 |
| 103 | Generalized myoclonic seizures (HP:0002123) | 2.04726002 |
| 104 | Genetic anticipation (HP:0003743) | 2.04653014 |
| 105 | Focal dystonia (HP:0004373) | 2.02195727 |
| 106 | Type II lissencephaly (HP:0007260) | 2.01984054 |
| 107 | Megalencephaly (HP:0001355) | 2.01333492 |
| 108 | Central scotoma (HP:0000603) | 2.01170887 |
| 109 | Congenital stationary night blindness (HP:0007642) | 2.01169564 |
| 110 | Inability to walk (HP:0002540) | 2.01090862 |
| 111 | Nephrogenic diabetes insipidus (HP:0009806) | 2.00931605 |
| 112 | Cystic liver disease (HP:0006706) | 1.98089705 |
| 113 | Polyphagia (HP:0002591) | 1.97394897 |
| 114 | Peripheral hypomyelination (HP:0007182) | 1.94980472 |
| 115 | Genital tract atresia (HP:0001827) | 1.94659154 |
| 116 | Clonus (HP:0002169) | 1.94305328 |
| 117 | Specific learning disability (HP:0001328) | 1.93381683 |
| 118 | Vaginal atresia (HP:0000148) | 1.92813369 |
| 119 | Psychosis (HP:0000709) | 1.92464164 |
| 120 | Agitation (HP:0000713) | 1.92406671 |
| 121 | Impaired vibratory sensation (HP:0002495) | 1.89383135 |
| 122 | Decreased circulating renin level (HP:0003351) | 1.89097324 |
| 123 | Acute necrotizing encephalopathy (HP:0006965) | 1.87859883 |
| 124 | Hyperactive renin-angiotensin system (HP:0000841) | 1.87738156 |
| 125 | Annular pancreas (HP:0001734) | 1.87264552 |
| 126 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.86961476 |
| 127 | True hermaphroditism (HP:0010459) | 1.86554584 |
| 128 | Dysostosis multiplex (HP:0000943) | 1.85916272 |
| 129 | Sensory axonal neuropathy (HP:0003390) | 1.85294222 |
| 130 | Stereotypic behavior (HP:0000733) | 1.84045355 |
| 131 | Craniofacial dystonia (HP:0012179) | 1.83688387 |
| 132 | Abnormal hair whorl (HP:0010721) | 1.82897491 |
| 133 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.82161006 |
| 134 | Akinesia (HP:0002304) | 1.79536724 |
| 135 | Rigidity (HP:0002063) | 1.79336588 |
| 136 | Abnormality of saccadic eye movements (HP:0000570) | 1.79128422 |
| 137 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.77521445 |
| 138 | Abnormal EKG (HP:0003115) | 1.77494913 |
| 139 | Pancreatic fibrosis (HP:0100732) | 1.76693542 |
| 140 | Gait ataxia (HP:0002066) | 1.74406085 |
| 141 | Hypothermia (HP:0002045) | 1.73991345 |
| 142 | Chronic hepatic failure (HP:0100626) | 1.73548288 |
| 143 | Neuronal loss in central nervous system (HP:0002529) | 1.73520001 |
| 144 | Blue irides (HP:0000635) | 1.71814177 |
| 145 | Esotropia (HP:0000565) | 1.68959770 |
| 146 | Renal salt wasting (HP:0000127) | 1.67296671 |
| 147 | Prolonged QT interval (HP:0001657) | 1.66966908 |
| 148 | Spinal canal stenosis (HP:0003416) | 1.66656504 |
| 149 | Congenital malformation of the right heart (HP:0011723) | 1.63871068 |
| 150 | Double outlet right ventricle (HP:0001719) | 1.63871068 |
| 151 | Hypercortisolism (HP:0001578) | 1.63432651 |
| 152 | Nuclear cataract (HP:0100018) | 1.62985768 |
| 153 | Abnormality of renin-angiotensin system (HP:0000847) | 1.62216421 |
| 154 | Adrenal overactivity (HP:0002717) | 1.59008020 |
| 155 | J-shaped sella turcica (HP:0002680) | 1.57245548 |
| 156 | Abnormality of the aortic arch (HP:0012303) | 1.57047729 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPK15 | 4.27897496 |
| 2 | NTRK3 | 4.22291641 |
| 3 | EPHA4 | 3.77426591 |
| 4 | MAP3K9 | 3.10546339 |
| 5 | ARAF | 2.84191757 |
| 6 | MAP3K4 | 2.59144889 |
| 7 | CASK | 2.44011446 |
| 8 | MINK1 | 2.35664845 |
| 9 | MAP2K7 | 2.34941325 |
| 10 | NTRK1 | 2.15192458 |
| 11 | MAP3K12 | 2.14706369 |
| 12 | PRPF4B | 2.14001026 |
| 13 | MARK1 | 2.10244761 |
| 14 | MAP3K11 | 2.03740968 |
| 15 | DAPK2 | 1.96726282 |
| 16 | PAK6 | 1.95040539 |
| 17 | PRKD3 | 1.95006556 |
| 18 | EPHA2 | 1.94413600 |
| 19 | TNIK | 1.88928890 |
| 20 | TRIB3 | 1.85105090 |
| 21 | KSR2 | 1.78745385 |
| 22 | NTRK2 | 1.76485897 |
| 23 | TESK1 | 1.72406139 |
| 24 | PNCK | 1.67032525 |
| 25 | CDK19 | 1.65214282 |
| 26 | GRK5 | 1.63683674 |
| 27 | UHMK1 | 1.63453059 |
| 28 | OXSR1 | 1.63240887 |
| 29 | BCKDK | 1.59277904 |
| 30 | STK39 | 1.54916757 |
| 31 | MAP2K4 | 1.50257235 |
| 32 | MAPK13 | 1.49621781 |
| 33 | RIPK4 | 1.47931249 |
| 34 | CDK5 | 1.46555323 |
| 35 | ERN1 | 1.41287620 |
| 36 | PLK2 | 1.40995044 |
| 37 | MAP2K6 | 1.33782059 |
| 38 | INSRR | 1.30479600 |
| 39 | CAMKK1 | 1.26870950 |
| 40 | SGK494 | 1.25911335 |
| 41 | SGK223 | 1.25911335 |
| 42 | RIPK1 | 1.22482703 |
| 43 | PRKCG | 1.15571847 |
| 44 | CAMK2A | 1.12332143 |
| 45 | CAMKK2 | 1.12196341 |
| 46 | MAP3K13 | 1.11948883 |
| 47 | PINK1 | 1.11874936 |
| 48 | CAMK2B | 1.11368619 |
| 49 | FES | 1.10273881 |
| 50 | KSR1 | 1.08112073 |
| 51 | BCR | 1.07684392 |
| 52 | DAPK1 | 1.07124948 |
| 53 | PHKG2 | 1.05540451 |
| 54 | PHKG1 | 1.05540451 |
| 55 | PRKD2 | 1.04136499 |
| 56 | SMG1 | 1.00035142 |
| 57 | MAP3K2 | 0.99726779 |
| 58 | TYRO3 | 0.99709246 |
| 59 | DYRK1B | 0.96604976 |
| 60 | SIK1 | 0.96406138 |
| 61 | TAOK1 | 0.94340577 |
| 62 | PRKCH | 0.94334534 |
| 63 | RPS6KA2 | 0.93683064 |
| 64 | BRAF | 0.93563253 |
| 65 | CAMK2D | 0.90891269 |
| 66 | CDK14 | 0.89760214 |
| 67 | PIM2 | 0.89262861 |
| 68 | CDK18 | 0.88110710 |
| 69 | HIPK2 | 0.86913292 |
| 70 | WNK4 | 0.86132417 |
| 71 | EPHB1 | 0.85756181 |
| 72 | AKT3 | 0.85564342 |
| 73 | CDK15 | 0.85478483 |
| 74 | STK38 | 0.85422225 |
| 75 | ICK | 0.84702718 |
| 76 | PRKCE | 0.83465903 |
| 77 | RAF1 | 0.82708489 |
| 78 | WNK1 | 0.81014725 |
| 79 | EPHA3 | 0.80629628 |
| 80 | NEK6 | 0.78870890 |
| 81 | TNK2 | 0.78116561 |
| 82 | MAP2K2 | 0.77401350 |
| 83 | MAPKAPK5 | 0.77320774 |
| 84 | GRK6 | 0.74585746 |
| 85 | TBK1 | 0.74061933 |
| 86 | CDK11A | 0.73814638 |
| 87 | CAMK2G | 0.73798880 |
| 88 | CCNB1 | 0.73325107 |
| 89 | PAK3 | 0.72635913 |
| 90 | BMPR2 | 0.71862382 |
| 91 | FGR | 0.70959784 |
| 92 | MAP3K7 | 0.69365281 |
| 93 | SGK2 | 0.68764418 |
| 94 | CSNK1G2 | 0.68756150 |
| 95 | MAPK12 | 0.68454402 |
| 96 | CAMK1 | 0.68214860 |
| 97 | PTK2B | 0.67556960 |
| 98 | DYRK1A | 0.66625168 |
| 99 | MUSK | 0.65109736 |
| 100 | NME1 | 0.63131357 |
| 101 | MAP3K1 | 0.62494244 |
| 102 | LMTK2 | 0.61315675 |
| 103 | ROCK2 | 0.61030772 |
| 104 | PRKCI | 0.60881629 |
| 105 | PKN1 | 0.60637589 |
| 106 | MAPKAPK3 | 0.59658150 |
| 107 | GRK7 | 0.59172145 |
| 108 | CSNK1A1L | 0.58899891 |
| 109 | RET | 0.56913065 |
| 110 | STK11 | 0.55564924 |
| 111 | FGFR2 | 0.53776062 |
| 112 | PRKAA1 | 0.53271888 |
| 113 | SGK1 | 0.52129267 |
| 114 | FYN | 0.49752162 |
| 115 | MARK2 | 0.48006727 |
| 116 | PDPK1 | 0.47888584 |
| 117 | CDC42BPA | 0.47705810 |
| 118 | MAP3K6 | 0.47359983 |
| 119 | WNK3 | 0.47090406 |
| 120 | LIMK1 | 0.46899102 |
| 121 | CSNK1G3 | 0.46663098 |
| 122 | PRKD1 | 0.45935085 |
| 123 | ADRBK2 | 0.43091277 |
| 124 | CAMK4 | 0.42625094 |
| 125 | TLK1 | 0.42563308 |
| 126 | FER | 0.41759277 |
| 127 | SIK2 | 0.41499727 |
| 128 | PRKACA | 0.41485774 |
| 129 | SGK3 | 0.41311584 |
| 130 | MAPK10 | 0.41284981 |
| 131 | ADRBK1 | 0.40055906 |
| 132 | EEF2K | 0.37950009 |
| 133 | RPS6KA3 | 0.37806098 |
| 134 | PDK1 | 0.37803760 |
| 135 | DAPK3 | 0.36702202 |
| 136 | PRKCZ | 0.36616339 |
| 137 | PRKCA | 0.36591763 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.62274916 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.50092135 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.86325669 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.80009458 |
| 5 | Olfactory transduction_Homo sapiens_hsa04740 | 2.75080235 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.66537536 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.60222733 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.55360425 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.29892520 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.29325208 |
| 11 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.26046625 |
| 12 | Insulin secretion_Homo sapiens_hsa04911 | 2.21502069 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.19332748 |
| 14 | Taste transduction_Homo sapiens_hsa04742 | 2.14273084 |
| 15 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.05805157 |
| 16 | Phototransduction_Homo sapiens_hsa04744 | 2.01118558 |
| 17 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.98206730 |
| 18 | Salivary secretion_Homo sapiens_hsa04970 | 1.96756494 |
| 19 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.93496557 |
| 20 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.70269791 |
| 21 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.66770332 |
| 22 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.66208185 |
| 23 | Cocaine addiction_Homo sapiens_hsa05030 | 1.64981507 |
| 24 | Long-term depression_Homo sapiens_hsa04730 | 1.59397416 |
| 25 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.54763654 |
| 26 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.53749399 |
| 27 | Renin secretion_Homo sapiens_hsa04924 | 1.52875089 |
| 28 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.51353085 |
| 29 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.47945519 |
| 30 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.47744044 |
| 31 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.46125188 |
| 32 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.41674410 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.39365625 |
| 34 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.25733662 |
| 35 | Alzheimers disease_Homo sapiens_hsa05010 | 1.23139926 |
| 36 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.19637673 |
| 37 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.18440455 |
| 38 | Gap junction_Homo sapiens_hsa04540 | 1.17777463 |
| 39 | Histidine metabolism_Homo sapiens_hsa00340 | 1.17196204 |
| 40 | Parkinsons disease_Homo sapiens_hsa05012 | 1.16831974 |
| 41 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.13286868 |
| 42 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.11064414 |
| 43 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.05848611 |
| 44 | Axon guidance_Homo sapiens_hsa04360 | 1.04777956 |
| 45 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.03399452 |
| 46 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.99894512 |
| 47 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.99549895 |
| 48 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.98590049 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.98502585 |
| 50 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.98017643 |
| 51 | Other glycan degradation_Homo sapiens_hsa00511 | 0.94310431 |
| 52 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.93489682 |
| 53 | Lysosome_Homo sapiens_hsa04142 | 0.90339492 |
| 54 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.89835850 |
| 55 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.89696134 |
| 56 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.89447740 |
| 57 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.89139288 |
| 58 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.86033331 |
| 59 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.85475464 |
| 60 | Melanogenesis_Homo sapiens_hsa04916 | 0.85407088 |
| 61 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.84982454 |
| 62 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.82841130 |
| 63 | Bile secretion_Homo sapiens_hsa04976 | 0.77961559 |
| 64 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.76245979 |
| 65 | Huntingtons disease_Homo sapiens_hsa05016 | 0.74121539 |
| 66 | ABC transporters_Homo sapiens_hsa02010 | 0.69342756 |
| 67 | Glioma_Homo sapiens_hsa05214 | 0.68792464 |
| 68 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.68705707 |
| 69 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.68298334 |
| 70 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.67741275 |
| 71 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.67580380 |
| 72 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.67426513 |
| 73 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.66925270 |
| 74 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.66242427 |
| 75 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.65596314 |
| 76 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.64588273 |
| 77 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.63384205 |
| 78 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.62229143 |
| 79 | Peroxisome_Homo sapiens_hsa04146 | 0.61341166 |
| 80 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.60692520 |
| 81 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.59721637 |
| 82 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.59522995 |
| 83 | Alcoholism_Homo sapiens_hsa05034 | 0.58892934 |
| 84 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.54417766 |
| 85 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.53301828 |
| 86 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.52598253 |
| 87 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.52249435 |
| 88 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52030599 |
| 89 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.51958052 |
| 90 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.51352864 |
| 91 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.50286985 |
| 92 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49704617 |
| 93 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.48332090 |
| 94 | Circadian rhythm_Homo sapiens_hsa04710 | 0.47071290 |
| 95 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46281959 |
| 96 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.45872504 |
| 97 | Sulfur relay system_Homo sapiens_hsa04122 | 0.42447092 |
| 98 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.41568663 |
| 99 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.41372846 |
| 100 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.41120950 |
| 101 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.40796090 |
| 102 | Endocytosis_Homo sapiens_hsa04144 | 0.40737754 |
| 103 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.40186509 |
| 104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.39952364 |
| 105 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.39498303 |
| 106 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.39422954 |
| 107 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.39242212 |
| 108 | Prion diseases_Homo sapiens_hsa05020 | 0.39159061 |
| 109 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.35236329 |
| 110 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.35150191 |
| 111 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.33856318 |
| 112 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.32051203 |
| 113 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.30971789 |
| 114 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.30963820 |
| 115 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.30388325 |
| 116 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.28717662 |
| 117 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.27798323 |
| 118 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.27467654 |
| 119 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.27336392 |
| 120 | Mineral absorption_Homo sapiens_hsa04978 | 0.27035805 |
| 121 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.26911921 |
| 122 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.22542775 |
| 123 | Phagosome_Homo sapiens_hsa04145 | 0.22425806 |

